Exploring Alleima AB (publ) Investor Profile: Who’s Buying and Why?

Exploring Alleima AB (publ) Investor Profile: Who’s Buying and Why?

SE | Basic Materials | Steel | LSE

Alleima AB (publ) (0ABJ.L) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Who's buying Alleima AB (0ABJ.L) and why? A close look at the shareholder registry shows a concentrated ownership base led by Industrivärden AB with a 21.09% stake (≈52,900,000 shares, ~SEK 465 million), LUNDBERG B at 10.04% (≈25,200,000 shares, ~SEK 222 million), Första AP-fonden at 4.99% (≈12,520,000 shares, ~SEK 110 million) and Swedbank Robur Fonder AB holding 4.157% (≈10,429,521 shares, ~SEK 92 million), while the top ten shareholders control roughly 54% of share capital and the free float stands at 79.63% (199,779,393 shares) - facts that underpin both liquidity and influential institutional sway; investors are drawn by Alleima's significant commitment to innovation (SEK 400 million R&D spend in 2022) and strategic pivot into hydrogen infrastructure and other high-growth end markets, even as Q2 2025 brought a 4% organic revenue decline and a 9.09% share price fall to SEK 73.50, offset by a resilient net cash position of SEK 33 million, a 6% reduction in CO2 emissions, and analyst support such as Pareto Securities' SEK 81 target - read on to see which investor types (institutional, mutual funds, private holders) are reshaping Alleima's ownership and how those stakes could influence strategy and market perception

Alleima AB (0ABJ.L) - Who Invests in Alleima AB (0ABJ.L) and Why?

Alleima attracts a diversified investor base-institutional investors, mutual funds and private individuals-drawn by its market position in advanced stainless and high-performance alloys, exposure to energy, chemical, aerospace and medical sectors, and an innovation- and sustainability-focused strategy.
  • Institutional investors: large, long-term holders such as Industrivärden AB and Första AP-fonden signal confidence in Alleima's strategy, balance sheet and predictable cash flows.
  • Mutual funds: asset managers including Swedbank Robur Fonder AB seek portfolio exposure to industrial technology and materials innovation with potential for stable returns.
  • Private investors: retail shareholders often cite Alleima's dividend policy and participation in energy transition markets (e.g., hydrogen infrastructure) as key attractions.
Investor Category Representative Holders Typical Investment Rationale
Institutions Industrivärden AB, Första AP-fonden Long-term scale exposure, corporate governance influence, confidence in cash generation
Mutual Funds Swedbank Robur Fonder AB (examples) Diversified fund exposure to industrial innovation and steady dividend prospects
Private / Retail Individual shareholders Dividend income, growth participation in sustainable energy and niche alloys
R&D Investment (2022) Approximately SEK 400 million allocated to research & development in 2022
Strategic Growth Focus Expanding presence in hydrogen infrastructure, specialized solutions for aerospace & medical markets
  • R&D spend (~SEK 400m in 2022) appeals to investors focused on innovation-driven growth and durable competitive advantage.
  • Strategic initiatives-notably moves into hydrogen infrastructure-draw interest from investors targeting emerging energy transition opportunities.
  • Dividend consistency and cash flow stability attract income-oriented retail and institutional investors alike.
Alleima AB (publ): History, Ownership, Mission, How It Works & Makes Money

Alleima AB (0ABJ.L) Institutional Ownership and Major Shareholders of Alleima AB (0ABJ.L)

Alleima AB displays a concentrated but liquid ownership structure with several large strategic and institutional holders controlling material stakes while a substantial free float supports market liquidity. The major holdings and their indicative SEK valuations (late 2025) are summarized below.
  • Industrivärden AB - largest single shareholder with a strategic 21.09% position (52,900,000 shares; ~SEK 465 million).
  • LUNDBERG B - significant industrial investor holding 10.04% (25,200,000 shares; ~SEK 222 million).
  • Första AP-fonden - public pension fund exposure at 4.99% (12,520,000 shares; ~SEK 110 million).
  • Swedbank Robur Fonder AB - active asset manager holding 4.157% (10,429,521 shares; ~SEK 92 million).
  • Top-ten concentration - roughly 54% of share capital held by the ten largest shareholders, indicating concentrated control and potential influence on governance.
  • Free float - 79.63% free float with 199,779,393 shares available for trading, supporting liquidity and market access for investors.
Shareholder Shares Stake (%) Indicative Value (SEK)
Industrivärden AB 52,900,000 21.09% ≈ 465,000,000
LUNDBERG B 25,200,000 10.04% ≈ 222,000,000
Första AP-fonden 12,520,000 4.99% ≈ 110,000,000
Swedbank Robur Fonder AB 10,429,521 4.157% ≈ 92,000,000
Top 10 shareholders (collective) - ≈54% -
Free float (shares available for trading) 199,779,393 79.63% -
For further context on Alleima's financial position that underpins investor conviction, see: Breaking Down Alleima AB (publ) Financial Health: Key Insights for Investors

Alleima AB (0ABJ.L) - Key Investors and Their Impact on Alleima AB (0ABJ.L)

Alleima's shareholder base is dominated by a handful of large Swedish institutional and family-owned investors whose positions and investment horizons materially affect governance, strategic choices and market perceptions.
  • Industrivärden AB - a large, long-term oriented industrial investor whose substantial stake aligns with strategic influence and active engagement in board- and capital-allocation matters.
  • LUNDBERG B (Lundbergföretagen) - represents concentrated family capital with a growth-focused, patient approach that can push for value-accretive initiatives and strong operational execution.
  • Första AP-fonden (AP1) - a large Swedish national pension fund, typically voting for sustainable, long-term returns and discipline in capital deployment.
  • Swedbank Robur Fonder AB - a major asset manager whose position signals confidence to retail and institutional clients and can amplify market trust in Alleima's prospects.
Investor Approx. Stake (%) Estimated Shares Held Latest Reporting Date Investor Type
Industrivärden AB ~9.5% ~31.5 million 2024-03-31 Investment company / Long-term
LUNDBERG B (Lundbergföretagen) ~7.0% ~23.2 million 2024-03-31 Family-controlled investment
Första AP-fonden (AP1) ~4.5% ~14.9 million 2024-03-31 Pension fund
Swedbank Robur Fonder AB ~3.2% ~10.6 million 2024-03-31 Asset manager
Other institutional holders (aggregated) ~25-35% ~80-115 million 2024-03-31 Mutual funds, pensions, insurers
  • Governance and strategic influence: Large concentrated stakes - especially Industrivärden and Lundbergföretagen - increase the probability of active engagement on board composition, dividend policy, M&A stance and capital allocation priorities.
  • Stability and credibility: AP1 and Swedbank Robur's participation signals institutional confidence, helping lower perceived governance risk and potentially improving access to capital on favorable terms.
  • Coordination risk/opportunity: Concentration raises the chance of coordinated actions (support for strategic initiatives or collective demands), which can accelerate strategic shifts or limit management flexibility.
  • Market signaling: Visible holdings by well-known Swedish investors attract additional domestic and international buyers seeking stable, governance-backed exposure to Alleima.
For background and fuller ownership history, see: Alleima AB (publ): History, Ownership, Mission, How It Works & Makes Money

Alleima AB (0ABJ.L) - Market Impact and Investor Sentiment

Alleima AB (0ABJ.L) saw immediate market reaction to its Q2 2025 results: a reported 4% organic revenue decline coincided with a 9.09% intraday share-price fall to SEK 73.50, underscoring investor sensitivity to near-term demand trends. Trading-day volatility was moderated by the company's diversified end-market exposure and continued balance-sheet strength.
  • Q2 2025 organic revenue change: -4%
  • Stock reaction (single-session): -9.09% to SEK 73.50
  • Net cash position (latest reported): SEK 33 million
  • CO2 emissions reduction (y/y): -6%
Operational performance was mixed across regions and segments:
  • Medical segment: strong performance, acted as revenue stabilizer
  • Europe & North America: weaker demand, primary contributors to organic decline
  • Diversification effect: medical strength helped dampen headline volatility
Analyst sentiment shows emerging confidence: Pareto Securities lifted its target price to SEK 81, reflecting expectations that strategic initiatives and cyclical recovery could restore margins and top-line growth. Market commentary and buy/sell interest align with a cautiously optimistic investor stance, balancing near-term macro pressures against structural positives (sustainability progress, net-cash balance).
Metric Value Context/Notes
Q2 2025 Organic Revenue Change -4% Reflects weaker demand in Europe & North America
Share Price Reaction (Q2 release) SEK 73.50 (-9.09%) Single-session drop on results publication
Net Cash Position SEK 33 million Provides financial flexibility and resilience
CO2 Emissions Reduction 6% Supports ESG-oriented investor demand
Notable Analyst Target SEK 81 (Pareto Securities) Indicates positive medium-term outlook among some brokers
Investor interest is concentrated among holders who prioritize balance-sheet strength, sustainability progress, and exposure to resilient end-markets (notably medical). For more on Alleima's background and strategic positioning, see Alleima AB (publ): History, Ownership, Mission, How It Works & Makes Money.

DCF model

Alleima AB (publ) (0ABJ.L) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.